Given its impressive revenue CAGR of 22 per cent through FY19-24 with improving profitability, analysts at Elara Capital expects strong growth to continue, though at moderated levels.
Based on the swap ratio recommended in the valuation report, the Aster promoters will hold 24 per cent and Blackstone 30.7 per cent in the merged entity
Aster coming together with Blackstone-backed Quality CARE will become one of the top three platforms in India, said Alisha Moopen, Deputy Managing Director of Aster DM Healthcare
At enterprise value of Rs 43,000 cr, merged entity set to be among top three players in India
The 254-bed Aster Adhaar Hospital in Kolhapur has received NABH (National Accreditation Board for Hospitals and Healthcare Providers) accreditation
Aster DM Healthcare on Wednesday said it has entered into an agreement to acquire the remaining 13 per cent stake in Prerana Hospital Ltd. Aster DM Healthcare had previously held 87 per cent stake in Prerana Hospital Ltd which owns 254-bedded 'Aster Adhaar Hospital' at Kolhapur in Maharashtra. "The transaction will be completed in two tranches and the indicative time period for completion of the acquisition is December 31, 2025," the company said in a statement. The consideration for the acquisition will be determined based on an independent valuation report in accordance with applicable laws, the company said in a regulatory filing. The complete acquisition of Prerana Hospital Ltd marks a significant milestone for Aster DM Healthcare in its continued growth and diversification strategy, the company said. "The complete acquisition aligns perfectly with our strategic goals to consolidate our presence in Western India. The expansion will also further build our customer base and deli
Stocks to watch on Monday, November 11, 2024: Here are few stocks that will be in spotlight
US-based private equity major Blackstone may hold a majority stake in merged entity
Eris Lifesciences, BLS International and Five-Star Business are the other 3 smallcap stocks that look favourably placed on the technical charts in an otherwise weak market.
Aster DM Healthcare stock skyrocketed 13.90 per cent at Rs 457.90 a piece on the NSE in Thursday's intraday deals
While the unlisted Quality Care India is valued at around Rs 16,826 crore ($2 billion) by bankers, Aster DM Healthcare's total market valuation was Rs 18,424 crore as of Monday
Hong Kong-based Olympus Capital Asia on Friday divested a 9 per cent stake in Hospital chain Aster DM Healthcare for Rs 1,530 crore through open market transactions. Investment firm Olympus Capital Asia, through its arm Olympus Capital Asia Investments, offloaded shares of Dubai-based Aster DM Healthcare on BSE. According to the bulk deal data available with BSE, Olympus Capital Asia Investments sold 4.50 crore shares or a 9 per cent stake in Aster DM Healthcare in two tranches. The shares were disposed of within the price range of Rs 340-340.13 apiece, taking the transaction value to Rs 1,530.08 crore. After the latest transaction, the shareholding of Olympus Capital Asia in Aster DM Healthcare has declined to 1.1 per cent from 10.1 per cent. Meanwhile, Franklin Templeton Mutual Fund, the Singapore government and Morgan Stanley Asia Singapore picked up a total of 1.24 crore shares of Aster DM Healthcare. The shares were purchased at an average price of Rs 340, taking the combine
Aster DM has appointed Alisha Moopen as the deputy managing director for a term of 5 years with effect from August 07, 2024
Aster CMI Hospital, located in Hebbal, Bengaluru, spans 445,000 square feet. With this development, the company is strengthening its presence in Bengaluru, bringing its total bed capacity to 1,602
Stocks to watch on Tuesday, April 16, 2024: Balrampur Chini, Bandhan Bank, Exide, GNFC, Hind Copper, India Cement, Metropolis, National Aluminium, PEL, SAIL and Zee are the 11 stocks in F&O ban today.
Aster DM Healthcare, which netted around USD 907 million from the sale of its GCC business, looks to plough around Rs 1,000 crore into its expansion plans in India as it targets a bed capacity of over 6,600 in the next three years. The healthcare company plans to add 1,700 beds by 2026-27 through organic and inorganic routes. The company's board last week also approved a special dividend of Rs 118 per share to its shareholders following the booster shot from the divestment of the GCC business. Aster DM Healthcare recently concluded the sale of its GCC businesses for a cash consideration of USD 907.6 million. The record date for determining the entitlement of the shareholders to special dividend is April 23, 2024. Aster DM Healthcare shares rallied more than 14 per cent on Monday to hit a fresh 52-week high on BSE, bucking a weak trend in the broader market. The stock hit a year high of Rs 558.30 per share before closing at Rs 522.75 on BSE, up by 7.13 per cent over the previous ..
Average trading volume on the counter jumped over four-fold in early delas with a combined 5.8 million equity shares changing hands on the NSE and BSE
Stocks to watch on Monday, April 15, 2024: IT shares, led by TCS, are expected to be in focus after the Tata group IT major reported better-than-expected Q4 numbers.
Aster DM has fixed April 23, 2024 as the 'Record Date' for determining entitlement of the shareholders to the interim dividend for the financial year 2023-24 and special dividend
Aster DM Healthcare on Wednesday said it has completed the separation of its India and GCC businesses. Under the separation plan, a consortium of investors led by Fajr Capital, a sovereign-backed private equity firm, has acquired a 65 per cent stake in Aster GCC, the company said in a statement. The Moopen family has retained a 35 per cent stake alongside management and operational rights, it added. In the Indian operations, the Moopen family continues to hold 41.88 per cent stake, the healthcare firm stated. "The transaction has now concluded, pursuant to which Affinity Holdings Ltd (a wholly-owned subsidiary of the company) has received a cash consideration of USD 907.6 million," the healthcare firm said. In November 2023, Aster DM Healthcare had obtained board approvals to separate its Gulf and India businesses.